Efficacy of aripiprazole combined with olanzapine for hospitalized male patients with schizophrenia and its effect on metabolic syndrome
BackgroundSchizophrenia and the use of antipsychotic medications are identified to be the likely contributors to the development of metabolic syndrome (MS) and cardiovascular disease, and jeopardize the prognosis of schizophrenia. Therefore, effectively preventing or reducing the risk of developing...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Sichuan Mental Health
2024-06-01
|
Series: | Sichuan jingshen weisheng |
Subjects: | |
Online Access: | http://www.psychjm.net.cn/scjswszzen/ch/reader/view_abstract.aspx?file_no=202403006&flag=1 |